ADMA Biologics Inc Receivables 2013-2024 | ADMA

ADMA Biologics Inc receivables for the quarter ending June 30, 2024 were $0.030B, a 18.02% decline year-over-year.

  • ADMA Biologics Inc receivables for 2023 were $0.027B, a 76.85% increase from 2022.
  • ADMA Biologics Inc receivables for 2022 were $0.016B, a 45.74% decline from 2021.
  • ADMA Biologics Inc receivables for 2021 were $0.029B, a 115.89% increase from 2020.

ADMA Biologics Inc Receivables 2013-2024 | ADMA

  • ADMA Biologics Inc receivables for 2023 were $0.027B, a 76.85% increase from 2022.
  • ADMA Biologics Inc receivables for 2022 were $0.016B, a 45.74% decline from 2021.
  • ADMA Biologics Inc receivables for 2021 were $0.029B, a 115.89% increase from 2020.